84 results on '"Thomas, Andreas'
Search Results
2. Diabetestechnologie: So kommt künstliche Intelligenz zum Einsatz: Das „Gehirn“ im Gerät
3. Automatische Insulinabgabe: Was heute möglich ist: Technologischer Fortschritt für Menschen mit Typ-1-Diabetes
4. Lebensstiländerungen - kontinuierliches Glukosemonitoring hilft dabei: Menschen mit Typ-2-Diabetes
5. Obstacle encounter probability dependent local path planner for UAV operation in urban environments
6. Improving local path planning for UAV flight in challenging environments by refining cost function weights
7. CGM verbessert Werte auch bei leichterem Typ-2-Diabetes
8. Glukosemessung und -kontrolle bei Patienten mit Typ-1- oder Typ-2-Diabetes
9. Diabetesmanagement heute: Wie neue Technologien die Patienten entlasten: Von der Überwachung des Blutzuckers zur intelligenten Therapiesteuerung
10. Bio-inspired altitude changing extension to the 3DVFH* local obstacle avoidance algorithm
11. Kann kontinuierliches Glukosemonitoring die computergestützte Insulintitration verbessern?
12. COVID-19 case rates, spatial mobility, and neighbourhood socioeconomic characteristics in Toronto: a spatial–temporal analysis
13. Prospective validation of 18F-Fluoroethylcholine as a tracer in PET/MRI for the evaluation of breast lesions and prediction of lymph node status
14. Complications of cochlear implants with MRI scans in different body regions: type, frequency and impact
15. Glukosemessung und -kontrolle bei Patienten mit Typ-1- oder Typ-2-Diabetes
16. Counter-regulatory responses to postprandial hypoglycaemia in patients with post-bariatric hypoglycaemia vs surgical and non-surgical control individuals
17. Automotive safety approach for future eVTOL vehicles
18. The Gerasimov-Drell-Hearn sum rule with nuclear targets
19. Investigations into the concentration and metabolite profiles of stanozolol and LGD-4033 in blood plasma and seminal fluid using liquid chromatography high-resolution mass spectrometry
20. Algorithmen für die automatisierte Insulindosierung (AID): ein Überblick
21. Phase I-metabolism studies of the synthetic cannabinoids PX-1 and PX-2 using three different in vitro models
22. Glukosemessung und -kontrolle bei Patienten mit Typ-1- oder Typ-2-Diabetes
23. Phenotypic characteristics and variability in CHARGE syndrome: a PRISMA compliant systematic review and meta-analysis
24. Can minimal clinically important differences in patient reported outcome measures be predicted by machine learning in patients with total knee or hip arthroplasty? A systematic review
25. Glukosesensor am rechten oder linken Arm?
26. Subjective burden and perspectives of German healthcare workers during the COVID-19 pandemic
27. Fetoscopic techniques for prenatal covering of gastroschisis in an ovine model are technically demanding and do not lead to permanent anchoring on the fetus until the end of gestation
28. Fully automated dried blood spot sample preparation enables the detection of lower molecular mass peptide and non-peptide doping agents by means of LC-HRMS
29. Phase I metabolic profiling of the synthetic cannabinoids THJ-018 and THJ-2201 in human urine in comparison to human liver microsome and cytochrome P450 isoenzyme incubation
30. In vitro metabolic profiling of synthetic cannabinoids by pooled human liver microsomes, cytochrome P450 isoenzymes, and Cunninghamella elegans and their detection in urine samples
31. A novel positive feedback-loop between the HTLV-1 oncoprotein Tax and NF-κB activity in T-cells
32. Post-mortem distribution of the synthetic cannabinoid MDMB-CHMICA and its metabolites in a case of combined drug intoxication
33. Organ distribution of 4-MEC, MDPV, methoxetamine and α-PVP: comparison of QuEChERS and SPE
34. Effects of different exercise intensities in the morning on football performance components in the afternoon
35. Analytical challenges in sports drug testing
36. Author Correction: Integrating standardized whole genome sequence analysis with a global Mycobacterium tuberculosis antibiotic resistance knowledgebase
37. Phylogenomic Perspective on a Unique Mycobacterium bovis Clade Dominating Bovine Tuberculosis Infections among Cattle and Buffalos in Northern Brazil
38. HSV-1 triggers paracrine fibroblast growth factor response from cortical brain cells via immediate-early protein ICP0
39. Impact of post-processing methods on apparent diffusion coefficient values
40. Simultaneous determination of insulin, DesB30 insulin, proinsulin, and C-peptide in human plasma samples by liquid chromatography coupled to high resolution mass spectrometry
41. Integrating standardized whole genome sequence analysis with a global Mycobacterium tuberculosis antibiotic resistance knowledgebase
42. Motorcycle helmet effectiveness in reducing head, face and brain injuries by state and helmet law
43. Analytics of nonpeptidic erythropoietin mimetic agents in sports drug testing employing high-resolution/high-accuracy liquid chromatography-mass spectrometry
44. In vitro elucidation of the metabolic profile of the synthetic cannabinoid receptor agonists JWH-175 and JWH-176
45. Qualitative identification of growth hormone-releasing hormones in human plasma by means of immunoaffinity purification and LC-HRMS/MS
46. EPOR-Based Purification and Analysis of Erythropoietin Mimetic Peptides from Human Urine by Cys-Specific Cleavage and LC/MS/MS
47. “Dilute-and-inject” multi-target screening assay for highly polar doping agents using hydrophilic interaction liquid chromatography high resolution/high accuracy mass spectrometry for sports drug testing
48. Determination of Synacthen® in dried blood spots for doping control analysis using liquid chromatography tandem mass spectrometry
49. Correction to: Post-mortem distribution of the synthetic cannabinoid MDMB-CHMICA and its metabolites in a case of combined drug intoxication
50. Identification of black market products and potential doping agents in Germany 2010–2013
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.